148 related articles for article (PubMed ID: 20922410)
21. Common phenotype and etiology in warfarin embryopathy and X-linked chondrodysplasia punctata (CDPX).
Savarirayan R
Pediatr Radiol; 1999 May; 29(5):322. PubMed ID: 10382206
[No Abstract] [Full Text] [Related]
22. A case of congenital warfarin syndrome due to maternal drug administration during the pregnancy.
Dilli D; Oğuz S; Dilmen U
Genet Couns; 2011; 22(2):221-6. PubMed ID: 21848016
[TBL] [Abstract][Full Text] [Related]
23. Warfarin therapy initiated during pregnancy and phenotypic chondrodysplasia punctata.
Pauli RM; Madden JD; Kranzler KJ; Culpepper W; Port R
J Pediatr; 1976 Mar; 88(3):506-8. PubMed ID: 1245966
[TBL] [Abstract][Full Text] [Related]
24. Low-dose maternal warfarin intake resulting in fetal warfarin syndrome: In search for a safe anticoagulant regimen during pregnancy.
Basu S; Aggarwal P; Kakani N; Kumar A
Birth Defects Res A Clin Mol Teratol; 2016 Feb; 106(2):142-7. PubMed ID: 26389802
[TBL] [Abstract][Full Text] [Related]
25. Chondrodysplasis punctata: is maternal warfarin therapy a factor?
Becker MH; Genieser NB; Finegold M; Miranda D; Spackman T
Am J Dis Child; 1975 Mar; 129(3):356-9. PubMed ID: 1121965
[No Abstract] [Full Text] [Related]
26. Relationship of maternal warfarin therapy in pregnancy to chondrodysplasia punctata: report of a case.
Collins P; Olufs R; Karvitz H; Babakitis M
Am J Obstet Gynecol; 1977 Feb; 127(4):444-6. PubMed ID: 835649
[No Abstract] [Full Text] [Related]
27. Correction of warfarin-induced nasal hypoplasia.
Bradley JP; Kawamoto HK; Taub P
Plast Reconstr Surg; 2003 Apr; 111(5):1680-7. PubMed ID: 12655214
[No Abstract] [Full Text] [Related]
28. Chondrodysplasia punctata and maternal warfarin use during pregnancy.
Shaul WL; Emery H; Hall JG
Am J Dis Child; 1975 Mar; 129(3):360-2. PubMed ID: 1121966
[No Abstract] [Full Text] [Related]
29. Motherisk rounds. Warfarin embryopathy following low-dose maternal exposure.
Finkelstein Y; Chitayat D; Schechter T; Keating S; Toi A; Koren G
J Obstet Gynaecol Can; 2005 Jul; 27(7):702-6. PubMed ID: 16100627
[No Abstract] [Full Text] [Related]
30. Severe nasomaxillary hypoplasia (Binder phenotype) on prenatal US/MRI: an important marker for the prenatal diagnosis of chondrodysplasia punctata.
Blask AR; Rubio EI; Chapman KA; Lawrence AK; Bulas DI
Pediatr Radiol; 2018 Jul; 48(7):979-991. PubMed ID: 29572747
[TBL] [Abstract][Full Text] [Related]
31. Maternal and fetal sequelae of anticoagulation during pregnancy.
Hall JG; Pauli RM; Wilson KM
Am J Med; 1980 Jan; 68(1):122-40. PubMed ID: 6985765
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulants.
de Swiet M
Br Med J (Clin Res Ed); 1987 Feb; 294(6569):428-30. PubMed ID: 3101910
[No Abstract] [Full Text] [Related]
33. Optic nerve dysfunction in a child following low-dose maternal warfarin exposure.
Khan AO
Ophthalmic Genet; 2007 Sep; 28(3):183-4. PubMed ID: 17896319
[TBL] [Abstract][Full Text] [Related]
34. A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy.
Franco B; Meroni G; Parenti G; Levilliers J; Bernard L; Gebbia M; Cox L; Maroteaux P; Sheffield L; Rappold GA; Andria G; Petit C; Ballabio A
Cell; 1995 Apr; 81(1):15-25. PubMed ID: 7720070
[TBL] [Abstract][Full Text] [Related]
35. Warfarin as a possible teratogen.
Fourie DT; Hay IT
S Afr Med J; 1975 Nov; 49(50):2081-3. PubMed ID: 1198244
[TBL] [Abstract][Full Text] [Related]
36. Two cases of warfarin embryopathy: a re-emergence of this condition?
Wellesley D; Moore I; Heard M; Keeton B
Br J Obstet Gynaecol; 1998 Jul; 105(7):805-6. PubMed ID: 9692425
[No Abstract] [Full Text] [Related]
37. An appraisal of warfarin therapy during pregnancy.
Kort HI; Cassel GA
S Afr Med J; 1981 Oct; 60(15):578-9. PubMed ID: 7280915
[TBL] [Abstract][Full Text] [Related]
38. Maxillonasal dysplasia (Binder's syndrome) and chondrodysplasia punctata.
Sheffield LJ; Halliday JL; Jensen F
J Med Genet; 1991 Jul; 28(7):503-4. PubMed ID: 1842210
[No Abstract] [Full Text] [Related]
39. The growth of the nasal septum in the 6-9 week period of foetal development--Warfarin embryopathy offers a new insight into prenatal facial development.
Howe AM; Hawkins JK; Webster WS
Aust Dent J; 2004 Dec; 49(4):171-6. PubMed ID: 15762337
[TBL] [Abstract][Full Text] [Related]
40. Prenatal diagnosis of warfarin embryopathy using three-dimensional ultrasound.
Gupta P; Kumar S; Roy KK; Sharma JB; Singh N
Int J Gynaecol Obstet; 2010 Nov; 111(2):184-5. PubMed ID: 20719312
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
